ፌብሩዋሪ 4፣ 2022፡- በህንድ ውስጥ ካንሰር ከባድ ማህበራዊ እና ኢኮኖሚያዊ ተጽእኖዎችን ሊያስከትል ይችላል, በተለይም የቤተሰብ እጦት እና የህብረተሰብ ኢፍትሃዊነትን ያስከትላል. በዚህ የስነ ሕዝብ አወቃቀር ታዳጊ አገር፣ በዕድሜ የተስተካከለ የካንሰር በሽታ መከሰቱ ሪፖርት የተደረገው አሁንም በጣም ዝቅተኛ ነው። በ1.3 ቢሊዮን ህዝብ ውስጥ በየአመቱ በትንሹ ከ1 ሚሊየን በላይ የሚሆኑ አዳዲስ የካንሰር አይነቶች ተገኝተዋል። በእድሜ በተስተካከሉ አገላለጾች፣ ይህ በምዕራብ አውሮፓ ከታዩት ወንድ እና ሴት ክስተቶች አራተኛውን ያንፀባርቃል። በሌላ በኩል ካንሰር እ.ኤ.አ. በ600000 በህንድ ውስጥ ከ700000–2012 ለሚገመቱ ግድያዎች ተጠያቂ ነበር።
በ IHME ጥናት ግሎባል ሸክም ኦፍ በሽታ ጥናት 2019 ትንታኔ መሠረት፣ ስዕሉ በተለይ በዓለም አቀፍ ደረጃ የተለየ አይደለም። እ.ኤ.አ. በ 2019 አዳዲስ የካንሰር ጉዳዮች ቁጥር ከ 23 ሚሊዮን አልፏል ፣ በ 18.7 ከ 2010 ሚሊዮን ፣ በ 2019 ፣ 10 ሚሊዮን የካንሰር ሞት ነበር ፣ በ 8.29 ከ 2010 ሚሊዮን ። እነዚህ ውጤቶች እንደቅደም ተከተል 20.9 በመቶ እና 26.3 በመቶ ጭማሪ አሳይተዋል። .
In both developing and developed countries, cancer is a leading cause of morbidity and mortality. The majority of the population in many low- and middle-income nations, including India, does not have access to a well-organized and well-regulated cancer care system. When a person is diagnosed with cancer, they are often forced to spend a lot of money on their own health. Such expenses can push entire families into poverty and, when paired with a lack of what are considered acceptable services, can jeopardize social stability. It can be easily said that cancer treatment in India is still in a nascent stage and huge development is required in this field.
There are two major problems cancer patients and their family members face when someone is diagnosed with cancer. One is, where will they get the best and most appropriate treatment, and two, how much money will be required for treatment? Second is the most important question, as the general population in India is still devoid of health insurance. We at CancerFax addresses both these problems. We help cancer patients find most appropriate and economical cancer treatment in India and abroad. CancerFax is working with more than 100 top cancer hospitals in 10 countries like Dana-Farber, Mayo Clinic, Boston Children’s Hospital, Sheba, Asan, Apollo, BLK, Artemis to name a few.
CAR T-Cell therapy is a breakthrough treatment for some kinds of lymphoma, leukemia and multiple myeloma. CancerFax helps patients enroll for CAR ቲ-ሴል ቴራፒ treatment in the USA, Israel and China. Many patients who had previously relapsed blood tumors had no evidence of cancer after CAR T-Cell therapy. It has also aided in the rehabilitation of patients who have previously failed to respond to most traditional cancer therapies. There are more than 300 ongoing clinical trials in the world’s leading cancer centers on this therapy. CAR T-Cell therapy in India is available as clinical trials now. I hope it will be available for commercial treatment very soon.
